The review gives data on the clinical manifestations, complications, and epidemiological characteristics of herpes zoster.


Cite item

Full Text

Abstract

It discusses prospects for and foreign experience with vaccination against chickenpox and exacerbations of herpes zoster. The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines

Full Text

Клинико-эпидемиологическая характеристика и вакцинопрофилактика опоясывающего лишая (herpes zoster). - Аннотация. В обзоре представлены данные о клинических проявлениях, осложнениях, эпидемиологических характеристиках опоясывающего лишая. Обсуждаются перспективы и зарубежный опыт вакцинопрофилактики ветряной оспы и обострений herpes zoster.
×

About the authors

N M Afonina

I V Mikheeva

Email: Irina_Mikheeva@mail.ru

References

  1. Покровский В.И., Пак С.Г., Брико Н.И., Данилкин Б.К. Инфекционные болезни и эпидемиология. М: ГЭОТАР-Медиа 2007; 832.
  2. Breuer J., Whitley R. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes 2007; 14 (Suppl. 2): 25-29.
  3. Черкасский Б.Л. Частная эпидемиология. Руководство для врачей. Т. 1. М: ИНТЕРСЭН 2002; 388.
  4. Atkinson W., Hamborsky J., McIntyre L., Wolfe S. (eds). Epidemiology and prevention of vaccine-preventable diseases, 10th ed. Washington DC: Public Health Foundation 2007: 175-196.
  5. Yoshikava T., Ihira M., Suzuki K. et al. Rapid contamination of varicella - zoster virus DNA from a patient with herpes zoster. J Med Virol 2001; 63 (l): 64-66.
  6. Johnson R.W., Rice A.S. Pain following herpes zoster: the influence of changing population characteristics and medical developments. Pain 2007; 128 (1-2): 3-5.
  7. Kennedy P.G., Grinfeld E., Gow J.W. Latent Varicella Zoster virus in human dorsal root ganglia. Virology 1999; 258 (2): 451-454.
  8. Zerboni L., Ku Chai-Chi, Jones C.D. et al. Varicella zoster virus infection of human dorsal root ganglia in vivo. Proc Nat Acad Sci USA 2005; 102 (18): 6490-6495.
  9. Loeser J.D. Herpes zoster and postherpetic neuralgia. Pain 1986; 25 (2): 149-164.
  10. Portenoy R.K., Duma C., Foley K.M. Acute herpetic and postherpetic neuralgia: clinical review аnd current management. Ann Neurol 1986; 20 (6): 651-664.
  11. Peter C., Watson N., Gershon A.A. (ed.) Herpes zoster and postherpetic neuralgia. Amsterdam etc.: Elsevier 2001: 280.
  12. Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека: руководство для врачей. СПб: Спецлит 2006; 301.
  13. Yawn B., Saddier P., Wollan P. et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341-1349.
  14. World Health Organization: The WHO position paper on varicella vaccines. Wkly Epidemiol Rec 1998; 73: 241-248.
  15. Strommen G.L., Pucino F., Tight R.R. et al. Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment. Pharmacotherapy 1988; 8 (1): 652-684.
  16. Scott F.T., Johnson R.W., Leedham-Green M. et al. The burden of herpes zoster: a prospective population based study. Vaccine 2006; 24: 1308-1314.
  17. National Advisory Committee on Immunization (NACI): Update to statement on varicella vaccine. An advisory committee statement (ACS). Can Commun Dis Rep 2002; 28: 1-7.
  18. Schmader K., Gnann J.W., Watson P. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008; 197 (Suppl. 2): 207-215.
  19. Chidiac C., Bruxelle J., Daures J.P. et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33: 62-69.
  20. Chapman R.S., Cross K., Fleming D.M. The incidence of shingles and its implications for vaccination policy. Vaccine 2003; 21: 2541-2547.
  21. Lancaster T., Silagy C., Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract 1995; 45: 39-45.
  22. Choo P., Galil K., Donahue J. et al. Risk factors for postherpetic neuralgia. Arch Intern Med 1997; 157: 1217-1224.
  23. Davies L., Cossins L., Bowsher D., Drummond M. The cost of treatment for postherpetic neuralgia in the UK. Phamacoeconomics 1994; 6: 142-148.
  24. Dworkin R.H., Portenoy R.K. Pain and its persistence in herpes zoster. Pain 1996; 67: 241-251.
  25. Волкова Л.И. Современные аспекты лечения и профилактики постгерпетической невралгии. Фармацевт вестн 2006; 16: 421.
  26. Иванова М.А. Эпидемиологическая, клинико-иммунологическая характеристика опоясывающего герпеса в Башкортостане: Автреф. дис. ... канд. мед. наук. Уфа 2007; 23.
  27. Attal N., Gruccu G., Haanpaa M. at al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169.
  28. Arvin A. Aging, immunity and the varicella zoster virus. N Engl J Med 2005; 352: 2266-2267.
  29. Kihara T., Shimohama S. Occipital neuralgia evoked by facial herpes zoster infection. Headache 2006; 46 (10): 1590-1591.
  30. Nishioka K., Fujishima K., Koba-yashi H. et al. An extremely unusual presentation of varicella zoster viral infection of cranial nerves mimicking Garcin syndrome. Clin Neurol Neurosurg 2006; 108 (8): 772-774.
  31. Степанченко A.B. Постгерпетическая тригеминальная невралгия. Нейроинфекции: матер. I Нац. конф. с междунар. уч. М 2007: 139-140.
  32. Cohrs R.J., Laguardia J.J., Gilden D. Distribution of latent herpes simplex virus type 1 and, varicella zoster virus DNA in human trigeminal ganglia. Virus Genes 2005; 31 (2): 223-227.
  33. Уманский К.Г., Смирнов Ю.К., Шишов A.C. Патогенетический анализ синдрома Рамзая Хунта. Журн невропатол и психиатр 1979; 8: 1011-1016.
  34. Шишов A.C., Вирыч И.Е., Багров Ф.И., Латышева И.Т. Синдром Гийена-Барре у больных опоясывающим лишаем. Журн неврол и психиатр 1996; 2: 26-29.
  35. Mancuso R., Delbue S., Borghi E. et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 2007; 79 (2): 192-199.
  36. Mancuso M., Virgili M.P., Pizzanelli C. et al. Abdominal pseudohernia caused by herpes zoster truncal D12 radiculoneuropathy. Arch Neurol 2006; 63 (9): 1327.
  37. Estraneo A., Saltalamacchia A.M., Loreto V. Spinal myoclonus following herpes zoster radiculitis. Neurology 2007; 68 (5): 149.
  38. Eyigor S., Durmaz B., Karapolat H. Monoparesis with complex regional pain syndrome-like symptoms due to brachial plexopathy caused by the varicella zoster virus: a case report. Arch Phys Med Rehabil 2006; 87 (12): 1653-1655.
  39. Mathis S., Gil R., Neau J.P. Neurological complications of Herpes zoster. Rev Neurol (Paris) 2006; 162 (8-9): 879-887.
  40. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4: 26-33.
  41. Gelb L.D. Varicella zoster virus infection. Current Opinion in Infectious Diseases 1989; 2: 256-261.
  42. Opstelten W., Van Essen G.A., Schellevis F. et al. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006; 16(9): 692-695.
  43. Grann J., Whitley R. Herpes Zoster. N Engl J Med 2002; 347: 340-346.
  44. Insinga R.P., Itzler R.F., Pellissier J.M. et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20: 748-53.
  45. Leung A.K., Robson W.L., Leong A.G. Herpes zoster in childhood. J. Pediatr. Health Care 2006; 20 (5): 300-303.
  46. Sauerbrei A., Wutzler P. Neonatal varicella. J Perinatol 2001; 21: 545-549.
  47. Sauerbrei A., Wutzler P. The congenital varicella syndrome. J Perinatol 2000; 20: 548-554.
  48. Sauerbrei A., Wutzler P. Varicella-zoster virus infections during pregnancy: epidemiology, clinical symptoms, diagnosis, prevention and therapy. Curr Pediat Rev 2005; 1: 205-216.
  49. West S.L., Newton R.W., Bail-dam E.M. et al. Recurrent hemiplegia associated with cerebral vasculopathy following third trimester maternal herpes zoster infection. Dev Med Child Neurol 2006; 48 (12): 991-993.
  50. Селькова Е.П. Эпидемиология ветряной оспы. Вакцинация 2009; 1: 5-7.
  51. Лобзин Ю.В. Руководство по инфекционным болезням. СПб: Фолиант 2000; 932.
  52. Серебряков М.Ю., Серебряков Д.Ю., Тищенко М.С. Лечение Herpes Zoster у больного с ВИЧ инфекцией. Венеролог 2005; 5: 77-78.
  53. Patel A.K., Patel K.K., Shah S.D., Desai J. Immune reconstitution syndrome presenting with cerebral varicella zoster vasculitis in HIV-1-infected patient: a case report. J. Int. Assoc. Physicians. AIDS Care. (Chic 111) 2006; 5 (4): 157-160.
  54. Grote V., von Kries R., Rosenfeld E. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis 2007; 196: 1455-1458.
  55. Jumaan A.O., Yu O., Jackson L.A. et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005; 191: 2002-2007.
  56. Tseng H.F., Smith N., Harpaz R. et al. Herpes zoster vaccine in older adults and the risk of subsequent zoster disease. JAMA 2011; 305: 160-166.
  57. Кимберлин Д.У., Уитли Р.Д. Профилактика опоясывающего лишая с помощью вакцины. РМЖ 2008; 16 (9): 5919.
  58. Moon M.A. Herpes Zoster Vaccine Effective in Real Practice. Fam Prac News. 2011 // [http://www.cdc.gov/shingles/downloads/fam-prac-news-zoster-vac.pdf].
  59. Barclay P., Murata P., Martin B.N. Guidelines Issued on Prevention of Herpes Zoster. MMWR Rep 2008; 57: 1-30.
  60. Coplan P.M., Schmader K., Nikas A. et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory. J Pain 2004; 5: 344-356.
  61. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of Herpes Zoster. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008; 57: 1-30.
  62. ACIP. Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices June 22, 2007 / 56(RR04): 1-40.
  63. Guess H.A., Broughton D.D., Melton L.J. et al. Population-based studies of varicella complications. Pediatrics 1986; 78 (Suppl. 1): 723-727.
  64. Hammerschlag M.R., Gershon A., Steinberg S. et al. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J Infect Dis 1989; 160: 535-537.
  65. Reynolds M.A., Chaves S.S., Harpaz R. et al. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197 (Suppl 2): 224-227.
  66. Wagenpfeil S., Neiss A., Wutzler P. Effect of varicella vaccination on herpes zoster incidence. Clin Microbiol Infect 2004; 10: 954-960.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies